New research has suggested that older men diagnosed with prostate cancer may not need any treatment. Now, a 15-year study shows that surgery is the best option for men under the age of 65.

You can't turn around without hearing praise for the health benefits of omega-3 fatty acids. Likewise, trans-fatty acids are considered one of the most unhealthful substances we can eat. Well, hold your horses - when it comes to prostate health, all that's wrong!

Men aged 65 and older who are diagnosed with a low-risk form of prostate cancer don't need to jump right into treatment. Delaying surgery and radiation doesn't pose added risk of death as long as the cancer is closely monitored.

A large clinical trial has demonstrated a new screening for prostate cancer that's more accurate than the tests currently available. In research conducted by Northwestern Medicine, the new PSA test reduced the number of false positives and pinpointed prostate cancer more precisely, particularly the aggressive form of the disease.

A new study shows that avoiding or controlling diabetes may reduce risks of developing or dying from cancer.

Certain prostate tumors have the potential to become metastatic if not treated aggressively, according to new research from Dana-Farber Cancer Institute.

A new RNA therapy has been shown to prevent prostate-cancer stem cells from replicating, thanks to new research from University of Texas MD Anderson Cancer Center.

The protein known as SIRT1 -- known for its life-spanning effects -- has been shown to inhibit prostatic intraepithelial neoplasia (PIN), which often prefigures prostate cancer.

Researchers at Duke Cancer Institute believe they have pinpointed why PSA (prostate-specific antigen) levels reflect cancer progression.

Interstitial brachytherapy may or may not hold advantages compared to other therapy options in men with localized prostate cancer, according to a new study.